The US Food and Drug Administration and pharmaceutical experts are paying close attention to the potential challenges the virus might pose -- and the danger that particular drugs could face shortages . 
The US China supply chain : The US relies heavily on Chinese made medical devices , drug ingredients and drugs for humans and animals ; as of 2018 , China ranked second among countries that exported drugs and biologics to the United States , and first for medical devices , according to the FDA . 
The FDA said it has identified about 20 drugs that either solely source their active pharmaceutical ingredients or produce finished drug products from or in China . 
" We have been in contact with those firms to understand if they face any drug shortage risks due to the outbreak . 
None of these firms has reported any shortage to date , " FDA spokesperson Stephanie Caccomo said Monday in a statement . 
" We will continue to remain in contact with the manufacturers so that we can best help mitigate any potential issues in the future . " 
